South Africa revises rules on compounding GLP-1 weight-loss drugs
South African health regulators are revising rules governing the customization of medicines, including GLP-1 treatments for diabetes and weight loss, warning pharmacies against acting as small-scale manufacturers. Officials are concerned about pharmacies compounding medicines ahead of demand, raising risks of counterfeit products.
2 sourcesGLP-1 medications
00